AbbVie 2012 Annual Report Download - page 44

Download and view the complete annual report

Please find page 44 of the 2012 AbbVie annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 200

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120
  • 121
  • 122
  • 123
  • 124
  • 125
  • 126
  • 127
  • 128
  • 129
  • 130
  • 131
  • 132
  • 133
  • 134
  • 135
  • 136
  • 137
  • 138
  • 139
  • 140
  • 141
  • 142
  • 143
  • 144
  • 145
  • 146
  • 147
  • 148
  • 149
  • 150
  • 151
  • 152
  • 153
  • 154
  • 155
  • 156
  • 157
  • 158
  • 159
  • 160
  • 161
  • 162
  • 163
  • 164
  • 165
  • 166
  • 167
  • 168
  • 169
  • 170
  • 171
  • 172
  • 173
  • 174
  • 175
  • 176
  • 177
  • 178
  • 179
  • 180
  • 181
  • 182
  • 183
  • 184
  • 185
  • 186
  • 187
  • 188
  • 189
  • 190
  • 191
  • 192
  • 193
  • 194
  • 195
  • 196
  • 197
  • 198
  • 199
  • 200

ITEM 6. SELECTED FINANCIAL DATA
The following table sets forth AbbVie’s selected financial information derived from its (i) unaudited
combined financial statements as of December 31, 2009 and 2008 and for the year ended December 31,
2008; and (ii) audited combined financial statements for the years ended December 31, 2012, 2011,
2010 and 2009 and as of December 31, 2012, 2011 and 2010. The historical financial information
presented may not be indicative of the results of operations or financial position that would have been
obtained if AbbVie had been an independent company during the periods shown or of AbbVie’s future
performance as an independent company.
The selected financial information should be read in conjunction with the combined financial
statements and accompanying notes and ‘‘Management’s Discussion and Analysis of Financial
Condition and Results of Operations.’’
as of and for the years ended December 31 (in millions, except
per share data) 2012 2011 2010 2009 2008
Combined statement of earnings data
Net sales $18,380 $17,444 $15,638 $14,214 $14,179
Net earnings 5,275 3,433 4,178 4,636 4,058
Basic and diluted earnings per common share 3.35 2.18 2.65 2.94 2.57
Basic and diluted average shares outstanding(a) 1,577 1,577 1,577 1,577 1,577
Combined balance sheet data
Total assets $27,008 $19,521 $21,135 $15,858 $16,601
Long-term debt and lease obligations(b) 14,652 48 52 55 64
(a) On January 1, 2013, Abbott Laboratories distributed 1,577 million shares of AbbVie common
stock. The computation of basic and diluted shares for all periods through December 31, 2012 is
calculated using the shares distributed on January 1, 2013. Refer to Note 2 to the combined
financial statements for information regarding earnings per common share.
(b) Also includes current portion of long-term debt and lease obligations.
38